vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Madison Square Garden Sports Corp. (MSGS). Click either name above to swap in a different company.
Madison Square Garden Sports Corp. is the larger business by last-quarter revenue ($403.4M vs $284.0M, roughly 1.4× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 2.0%, a 94.3% gap on every dollar of revenue. On growth, Madison Square Garden Sports Corp. posted the faster year-over-year revenue change (12.8% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs -3.1%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Madison Square Garden Sports Corp. is an American sports holding company based in New York City.
ACAD vs MSGS — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $403.4M |
| Net Profit | $273.6M | $8.2M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | 5.5% |
| Net Margin | 96.3% | 2.0% |
| Revenue YoY | 9.4% | 12.8% |
| Net Profit YoY | 90.3% | 641.9% |
| EPS (diluted) | $1.61 | $0.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $403.4M | ||
| Q3 25 | $278.6M | $39.5M | ||
| Q2 25 | $264.6M | $204.0M | ||
| Q1 25 | $244.3M | $424.2M | ||
| Q4 24 | $259.6M | $357.8M | ||
| Q3 24 | $250.4M | $53.3M | ||
| Q2 24 | $242.0M | $227.3M | ||
| Q1 24 | $205.8M | $430.0M |
| Q4 25 | $273.6M | $8.2M | ||
| Q3 25 | $71.8M | $-8.8M | ||
| Q2 25 | $26.7M | $-1.8M | ||
| Q1 25 | $19.0M | $-14.2M | ||
| Q4 24 | $143.7M | $1.1M | ||
| Q3 24 | $32.8M | $-7.5M | ||
| Q2 24 | $33.4M | $25.5M | ||
| Q1 24 | $16.6M | $37.9M |
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — | ||
| Q1 24 | 88.8% | — |
| Q4 25 | 6.1% | 5.5% | ||
| Q3 25 | 12.8% | -69.5% | ||
| Q2 25 | 12.2% | -11.1% | ||
| Q1 25 | 7.9% | 7.6% | ||
| Q4 24 | 59.1% | 3.7% | ||
| Q3 24 | 12.6% | -15.5% | ||
| Q2 24 | 12.6% | 23.0% | ||
| Q1 24 | 7.4% | 18.5% |
| Q4 25 | 96.3% | 2.0% | ||
| Q3 25 | 25.8% | -22.3% | ||
| Q2 25 | 10.1% | -0.9% | ||
| Q1 25 | 7.8% | -3.4% | ||
| Q4 24 | 55.4% | 0.3% | ||
| Q3 24 | 13.1% | -14.1% | ||
| Q2 24 | 13.8% | 11.2% | ||
| Q1 24 | 8.0% | 8.8% |
| Q4 25 | $1.61 | $0.34 | ||
| Q3 25 | $0.42 | $-0.37 | ||
| Q2 25 | $0.16 | $-0.08 | ||
| Q1 25 | $0.11 | $-0.59 | ||
| Q4 24 | $0.86 | $0.05 | ||
| Q3 24 | $0.20 | $-0.31 | ||
| Q2 24 | $0.20 | $1.07 | ||
| Q1 24 | $0.10 | $1.57 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $81.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $-282.1M |
| Total Assets | $1.6B | $1.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $81.3M | ||
| Q3 25 | $258.0M | $48.6M | ||
| Q2 25 | $253.6M | $144.6M | ||
| Q1 25 | $217.7M | $96.5M | ||
| Q4 24 | $319.6M | $107.8M | ||
| Q3 24 | $155.1M | $52.3M | ||
| Q2 24 | $177.1M | $89.1M | ||
| Q1 24 | $204.7M | $40.0M |
| Q4 25 | $1.2B | $-282.1M | ||
| Q3 25 | $917.3M | $-294.2M | ||
| Q2 25 | $822.4M | $-281.4M | ||
| Q1 25 | $765.2M | $-283.4M | ||
| Q4 24 | $732.8M | $-273.1M | ||
| Q3 24 | $577.2M | $-277.5M | ||
| Q2 24 | $516.7M | $-266.3M | ||
| Q1 24 | $464.0M | $-294.0M |
| Q4 25 | $1.6B | $1.5B | ||
| Q3 25 | $1.3B | $1.5B | ||
| Q2 25 | $1.2B | $1.5B | ||
| Q1 25 | $1.1B | $1.5B | ||
| Q4 24 | $1.2B | $1.4B | ||
| Q3 24 | $976.9M | $1.4B | ||
| Q2 24 | $914.1M | $1.3B | ||
| Q1 24 | $855.1M | $1.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $32.4M |
| Free Cash FlowOCF − Capex | — | $31.6M |
| FCF MarginFCF / Revenue | — | 7.8% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | -0.18× | 3.94× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-480.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $32.4M | ||
| Q3 25 | $74.3M | $-85.0M | ||
| Q2 25 | $64.0M | $49.7M | ||
| Q1 25 | $20.3M | $6.3M | ||
| Q4 24 | $40.4M | $61.8M | ||
| Q3 24 | $63.2M | $-26.2M | ||
| Q2 24 | $25.0M | $108.4M | ||
| Q1 24 | $29.1M | $4.0M |
| Q4 25 | — | $31.6M | ||
| Q3 25 | $73.9M | $-85.3M | ||
| Q2 25 | — | $49.4M | ||
| Q1 25 | — | $3.9M | ||
| Q4 24 | — | $61.2M | ||
| Q3 24 | $63.2M | $-26.5M | ||
| Q2 24 | — | $108.0M | ||
| Q1 24 | — | $3.9M |
| Q4 25 | — | 7.8% | ||
| Q3 25 | 26.5% | -216.3% | ||
| Q2 25 | — | 24.2% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 17.1% | ||
| Q3 24 | 25.2% | -49.7% | ||
| Q2 24 | — | 47.5% | ||
| Q1 24 | — | 0.9% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | 0.1% | 0.9% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | -0.18× | 3.94× | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 0.28× | 55.61× | ||
| Q3 24 | 1.93× | — | ||
| Q2 24 | 0.75× | 4.25× | ||
| Q1 24 | 1.76× | 0.11× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
MSGS
| Event Related | $167.2M | 41% |
| Media Rights | $122.3M | 30% |
| Sponsorship Signage And Suite Licenses | $98.5M | 24% |
| League Distribution | $15.4M | 4% |
